MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P. Medical Co., Ltd. (Representative Director: Yuji Matsumaru; Address: 3-11-5 Nihonbashi-Honcho, Chuo-ku, Tokyo), a company developing a transcutaneous transvascular electroencephalography device to identify focal location in intractable epilepsy. Details are attachedThis PDF (external link)Please check.

Fiscal Year 2021「Medical and Engineering Collaboration Innovation Promotion Project (Development and Commercialization Project)」About the selected projects